Towards the use of cannabinoids as antitumour agents.

Nature Reviews. Cancer
Guillermo VelascoManuel Guzmán

Abstract

Various reports have shown that cannabinoids (the active components of marijuana and their derivatives) can reduce tumour growth and progression in animal models of cancer, in addition to their well-known palliative effects on some cancer-associated symptoms. This Opinion article discusses our current understanding of cannabinoids as antitumour agents, focusing on recent insights into the molecular mechanisms of action, including emerging resistance mechanisms and opportunities for combination therapy approaches. Such knowledge is required for the optimization of preclinical cannabinoid-based therapies and for the preliminary clinical testing that is currently underway.

References

Oct 4, 1995·Biochemical and Biophysical Research Communications·T SugiuraK Waku
Mar 1, 1996·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·P C ChanJ R Bucher
Jun 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·L X ZhuS M Dubinett
Nov 1, 2000·The Journal of Biological Chemistry·J A EncinarJ L Iovanna
Apr 9, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M ThurnherL Höltl
Nov 1, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M BifulcoV Di Marzo
Feb 2, 2002·Experimental Hematology·Marieke JoostenRuud Delwel
Mar 21, 2002·The Biochemical Journal·Teresa Gómez del PulgarManuel Guzmán
Jan 4, 2003·The Journal of Clinical Investigation·M Llanos CasanovaManuel Guzmán
Jan 7, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Cristina BlázquezManuel Guzmán
May 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Charles G Smith, John R Vane
Sep 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Giuseppe PortellaMaurizio Bifulco
Oct 23, 2003·Nature Reviews. Cancer·Manuel Guzmán
Aug 18, 2004·Cancer Research·Cristina BlázquezManuel Guzmán
Sep 29, 2004·Cellular Signalling·Aleksandra Ellert-MiklaszewskaLiliana Konarska
Mar 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Robert J McKallipPrakash S Nagarkatti
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Apr 26, 2005·Cancer Treatment Reviews·Sara LonardiAlba A Brandes
Jun 15, 2005·Annual Review of Biochemistry·Martin Schröder, Randal J Kaufman
Dec 14, 2005·Experimental Cell Research·Claudia GrimaldiMaurizio Bifulco
Apr 18, 2006·Cancer Cell·Arkaitz CarracedoGuillermo Velasco
May 27, 2006·The Journal of Pharmacology and Experimental Therapeutics·Alessia LigrestiVincenzo Di Marzo
Jul 14, 2006·The Journal of Pharmacology and Experimental Therapeutics·Tangying LuThomas W Klein
Aug 1, 2006·Critical Reviews in Oncology/hematology·Carsten NiederAnca L Grosu
Aug 16, 2006·Cellular and Molecular Life Sciences : CMLS·P MassiD Parolaro
Sep 14, 2006·Pharmacological Reviews·Pál PacherGeorge Kunos
Oct 27, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Cristina BlázquezManuel Guzmán
Dec 5, 2006·Trends in Pharmacological Sciences·Javier Fernández-RuizManuel Guzmán

❮ Previous
Next ❯

Citations

Apr 23, 2013·Trends in Pharmacological Sciences·Simona PisantiMaurizio Bifulco
Jun 12, 2013·PloS One·Mariateresa CiprianoChristopher J Fowler
Sep 30, 2014·Colloids and Surfaces. B, Biointerfaces·Lucía Martín-BanderasMercedes Fernández-Arévalo
Aug 30, 2014·Cell Death and Differentiation·M SalazarG Velasco
Jan 1, 2014·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Barbara RomanoAngelo A Izzo
Feb 9, 2016·European Journal of Pharmacology·Farideh A JavidAlessia Ligresti
Feb 3, 2016·Journal of Natural Products·Oier Aizpurua-OlaizolaAresatz Usobiaga
Feb 13, 2015·The Journal of Investigative Dermatology·Jane L ArmstrongPenny E Lovat
Aug 2, 2012·British Journal of Pharmacology·Pál Pacher
Feb 6, 2015·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Xiaona ZhengMorioh Kusakabe
Dec 17, 2014·CA: a Cancer Journal for Clinicians·Joan L Kramer
May 14, 2014·The Journal of Pharmacy and Pharmacology·Natasha BeukesCarminita L Frost
Mar 18, 2015·Clinical Pharmacology and Therapeutics·D I Abrams, M Guzman
Apr 23, 2015·International Journal of Pharmaceutics·L Martín-BanderasM Fernández-Arévalo
Jun 15, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Guillermo VelascoMar Lorente
Jul 11, 2012·Cancer Treatment Reviews·María M CaffarelCristina Sánchez
Feb 11, 2014·Current Opinion in Cell Biology·Morgan O'HayreJ Silvio Gutkind
Apr 10, 2013·Biochimica Et Biophysica Acta·María SalazarGuillermo Velasco
Oct 24, 2013·Biochemical and Biophysical Research Communications·Paul L PratherAnna Radominska-Pandya
Jul 3, 2015·Oncoimmunology·Aitziber BuquéLorenzo Galluzzi
Apr 29, 2015·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Sean D McAllisterPierre-Yves Desprez
May 11, 2015·Human Reproduction Update·Thangesweran AyakannuJustin C Konje
Dec 25, 2012·Pharmacology & Therapeutics·Vincenzo MicaleFilippo Drago
Apr 10, 2015·Journal of the National Cancer Institute·Eduardo Pérez-GómezCristina Sánchez
Oct 22, 2013·European Journal of Medicinal Chemistry·Paula MoralesNadine Jagerovic
Mar 2, 2013·Oncology Nursing Forum·Susan Weiss Behrend
May 25, 2016·Expert Opinion on Therapeutic Patents·Paula MoralesNadine Jagerovic
Oct 21, 2016·Redox Biology·Agnieszka GęgotekElżbieta Skrzydlewska
Aug 27, 2016·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·C HasenoehrlR Schicho
Nov 1, 2016·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Simone Treiger SredniTadanori Tomita
Apr 14, 2016·Expert Opinion on Therapeutic Targets·Robert Ramer, Burkhard Hinz
Nov 12, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Susan FungNephi Stella

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Treatment Reviews
María M CaffarelCristina Sánchez
Current Topics in Medicinal Chemistry
Christopher J FowlerAnders Bergh
The Journal of Pharmacology and Experimental Therapeutics
Nadine FreimuthBurkhard Hinz
© 2021 Meta ULC. All rights reserved